Miguel Alcoceba

Miguel Alcoceba

UNVERIFIED PROFILE

Are you Miguel Alcoceba?   Register this Author

Register author
Miguel Alcoceba

Miguel Alcoceba

Publications by authors named "Miguel Alcoceba"

Are you Miguel Alcoceba?   Register this Author

50Publications

2558Reads

12Profile Views

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma.

Hematol Oncol 2019 Apr 8;37(2):215-218. Epub 2019 Jan 8.

Centro de Investigación del Cáncer de Salamanca; Servicio de Hematología, Hospital Universitario de Salamanca; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/hon.2570
Publisher Site
http://dx.doi.org/10.1002/hon.2570DOI Listing
April 2019

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome.

Hematol Oncol 2017 Dec 3;35(4):520-527. Epub 2017 Feb 3.

Department of Clinical Hematology. ICO-Badalona, Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2378DOI Listing
December 2017

Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report.

Medicine (Baltimore) 2017 May;96(19):e6846

aDepartment of Obstetrics and Gynecology bDepartment of Pathology cDepartment of Radiology dDepartment of Hematology eUniversity Hospital of Salamanca (IBSAL-HUS) fCIBERONC, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000006846DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428606PMC
May 2017

CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.

J Pathol 2015 Feb 11;235(3):445-55. Epub 2014 Dec 11.

Grup d'Oncogènesi i Antitumorals, lnstitut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat de Barcelona, Spain; CIBER en Bioingeniería, Biomateriales y Nanomecidicina (CIBER-BBN), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4446DOI Listing
February 2015